CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the Maxim Group Growth Conference on Thursday, September 20, 2007, at 11:00 a.m. ET at the Grand Hyatt Hotel in New York City.
